Dr Daniel Saunders

Title: Consultant Clinical Oncologist




Radiotherapy, Chemotherapy, Hormonal Therapy, Biological Therapy

Current NHS Post

Nottingham City Hospital

Year Qualified


Clinical Interests

Urology, Germ Cell Tumours, Kidney Tumours, Sarcoma, Rare Cancers

Research Interests

Radiotherapy for paediatric renal tumours, advanced radiotherapy for prostate and bladder cancer

Professional Memberships
  • Fellow of the Royal College of Radiologists
  • Children’s Cancer and Leukaemia Group
  • Paediatric Radiation Oncology Society
  • SIOP Wilms’ Tumour Group

Dr Daniel Saunders has been a consultant in clinical oncology in Nottingham since 2009 and became Head of Service at NUH in 2011. He co-developed a successful prostate IMRT programme at NUH and is involved in establishing a national clinical trial using advanced IG-IMRT  for patients with bladder cancer. He has a particular interest in paediatric radiotherapy and the treatment of uncommon tumours using advanced oncological techniques. Dr Saunders passionately believes that, despite the significant advances in treatment technology that patients deserve an individualised approach which integrates evidence on best available practice with their individual needs.

Latest News

  • October 3, 2015
    Early Docetaxel for prostate cancer improves survival

    Early treatment with Docetaxel chemotherapy imp...

    Read More
  • July 30, 2015
    Prostate Cancer Genetic Signatures

    A better understanding of the genetics of prost...

    Read More
  • May 13, 2015
    Where are the voices for radiotherapy?

    It is not well publicised – but the main ...

    Read More